Download original image
Fig. 2.
Survival analysis of radical surgery versus systemic therapy alone, in the setting of low-volume metastatic disease. (A) Overall survival (OS); (B) disease-free survival (DFS).
Ann Hepatobiliary Pancreat Surg 2023;27:180-8
https://doi.org/10.14701/ahbps.22-111
© 2023 Ann Hepatobiliary Pancreat Surg
